Crane (NYSE:CR) Posts Quarterly Earnings Results, Beats Estimates By $0.23 EPS
Crane (NYSE:CR) Posts Quarterly Earnings Results, Beats Estimates By $0.23 EPS
Crane (NYSE:CR – Get Rating) issued its quarterly earnings data on Monday. The conglomerate reported $2.13 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.90 by $0.23, MarketWatch Earnings reports. Crane had a net margin of 13.10% and a return on equity of 24.93%. The business had revenue of $824.10 million during the quarter, compared to analyst estimates of $819.89 million. During the same quarter last year, the business earned $1.25 EPS. The firm's quarterly revenue was down .1% on a year-over-year basis.
Crane(纽约证券交易所代码:CR-GET Rating)周一发布了季度收益数据。MarketWatch收益报告显示,这家企业集团公布本季度每股收益为2.13美元,超出分析师普遍预期的1.90美元,超出0.23美元。克兰的净利润率为13.10%,股本回报率为24.93%。该业务本季度营收为8.241亿美元,而分析师预期为8.1989亿美元。去年同期,该业务每股收益为1.25美元。该公司的季度收入同比下降了1.1%。
Crane Price Performance
起重机性价比
Shares of NYSE CR opened at $115.50 on Wednesday. The stock's 50 day moving average price is $103.55 and its 200-day moving average price is $99.03. The company has a market capitalization of $6.48 billion, a PE ratio of 16.74, a PEG ratio of 1.45 and a beta of 1.51. Crane has a twelve month low of $82.14 and a twelve month high of $116.11. The company has a quick ratio of 0.97, a current ratio of 1.38 and a debt-to-equity ratio of 0.49.
周三,纽约证交所CR的股价开盘报115.50美元。该股的50日移动均线价格为103.55美元,200日移动均线价格为99.03美元。该公司市值为64.8亿美元,市盈率为16.74倍,聚乙二醇率为1.45倍,贝塔系数为1.51。Crane的12个月低点为82.14美元,12个月高位为116.11美元。该公司的速动比率为0.97,流动比率为1.38,债务权益比率为0.49。
Insider Buying and Selling
内幕买卖
In other news, SVP Alejandro Alcala sold 25,649 shares of the firm's stock in a transaction on Monday, November 7th. The stock was sold at an average price of $104.38, for a total transaction of $2,677,242.62. Following the completion of the sale, the senior vice president now directly owns 22,177 shares of the company's stock, valued at approximately $2,314,835.26. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. In related news, SVP Kurt F. Gallo sold 2,750 shares of Crane stock in a transaction that occurred on Wednesday, November 23rd. The shares were sold at an average price of $105.53, for a total value of $290,207.50. Following the sale, the senior vice president now owns 25,845 shares of the company's stock, valued at approximately $2,727,422.85. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Alejandro Alcala sold 25,649 shares of the stock in a transaction on Monday, November 7th. The shares were sold at an average price of $104.38, for a total value of $2,677,242.62. Following the transaction, the senior vice president now directly owns 22,177 shares of the company's stock, valued at $2,314,835.26. The disclosure for this sale can be found here. Over the last three months, insiders have sold 151,409 shares of company stock worth $15,809,162. 2.40% of the stock is owned by company insiders.
在其他新闻方面,高级副总裁亚历杭德罗·阿尔卡拉在11月7日星期一的交易中出售了25,649股该公司的股票。股票以104.38美元的平均价格出售,总成交金额为2677,242.62美元。出售完成后,高级副总裁现在直接持有该公司22,177股股票,价值约2,314,835.26美元。这笔交易是在提交给美国证券交易委员会的一份法律文件中披露的,该文件可在以下网址获得美国证券交易委员会网站。在相关新闻中,高级副总裁库尔特·F·加洛在11月23日星期三的一笔交易中出售了2,750股克兰的股票。这些股票的平均价格为105.53美元,总价值为290,207.50美元。出售后,高级副总裁现在拥有该公司25,845股股票,价值约2,727,422.85美元。这笔交易是在提交给美国证券交易委员会的一份法律文件中披露的,该文件可在美国证券交易委员会网站。此外,高级副总裁亚历杭德罗·阿尔卡拉在11月7日星期一的交易中出售了25,649股该股。这些股票的平均价格为104.38美元,总价值为2,677,242.62美元。交易完成后,高级副总裁现在直接持有该公司22,177股股票,价值2,314,835.26美元。关于这次销售的披露可以找到这里。在过去的三个月里,内部人士已经出售了151,409股公司股票,价值15,809,162美元。2.40%的股份由公司内部人士持有。
Institutional Inflows and Outflows
机构资金流入和流出
Wall Street Analyst Weigh In
华尔街分析师也加入进来
A number of equities analysts have recently commented on the stock. StockNews.com lowered shares of Crane from a "strong-buy" rating to a "buy" rating in a report on Wednesday, October 26th. TheStreet raised Crane from a "c+" rating to a "b-" rating in a research note on Thursday, November 10th. Morgan Stanley raised shares of Crane from an "equal weight" rating to an "overweight" rating and increased their target price for the company from $116.00 to $129.00 in a research report on Monday, December 12th. Finally, Stifel Nicolaus cut their target price on Crane from $123.00 to $121.00 and set a "buy" rating on the stock in a research report on Tuesday, October 11th. Four investment analysts have rated the stock with a buy rating, According to MarketBeat.com, the company presently has a consensus rating of "Buy" and an average price target of $125.00.
一些股票分析师最近对该股发表了评论。在10月26日星期三的一份报告中,StockNews.com将Crane的股票评级从“强力买入”下调至“买入”。华尔街在11月10日星期四的一份研究报告中将Crane的评级从“c+”上调至“b-”。摩根士丹利12日(周一)在一份研究报告中将克兰的股票评级从持平上调至增持,并将该公司的目标价从116.00美元上调至129.00美元。最后,Stifel Nicolaus在10月11日周二的一份研究报告中将其对Crane的目标价从123.00美元下调至121.00美元,并对该股设定了“买入”评级。根据MarketBeat.com的数据,四位投资分析师对该股的评级为买入,目前该公司的普遍评级为买入,平均目标价为125.00美元。
Crane Company Profile
起重机公司简介
(Get Rating)
(获取评级)
Crane Holdings Co engages in the management of a subsidiary, which manufacture aerospace equipment, electronics systems, and flow control systems. The company was founded on December 2, 2021 and is headquartered in Stamford, CT.
起重机控股公司从事一家子公司的管理,该子公司制造航空航天设备、电子系统和流量控制系统。该公司成立于2021年12月2日,总部设在康涅狄格州斯坦福德。
Recommended Stories
推荐故事
- Get a free copy of the StockNews.com research report on Crane (CR)
- Pliant Therapeutics Gaps 34% Higher: More Upside To Come?
- How Will Early 2023 Layoffs Affect These 5 Biotech Stocks?
- Is the Pain Over for Baudax Bio Investors after a 70% Spike?
- Will Rocket Lab's First U.S. Launch Send Stock Into Stratosphere?
- When Will Crane Holdings Take Flight?
- 免费获取StockNews.com关于Crane的研究报告(CR)
- 柔顺治疗公司的差距增加了34%:未来还会有更多的好处吗?
- 2023年初裁员将如何影响这5只生物科技股?
- Baudax Bio投资者在经历了70%的飙升后,痛苦是否已经结束?
- 火箭实验室的首次美国发射将把斯托克送入平流层吗?
- Crane Holdings什么时候起飞?
Receive News & Ratings for Crane Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crane and related companies with MarketBeat.com's FREE daily email newsletter.
接受《鹤日报》的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对Crane和相关公司的最新新闻和分析师评级的每日简要摘要。